Flonoltinib
Flonoltinib is a potent and orally active dual JAK2/FLT3 inhibitor with IC50 values of 0.7 nM, 4 nM, 26 nM and 39 nM for JAK2, FLT3, JAK1 and JAK3, respectively. Flonoltinib has anti-cancer activity[1].
Product Specifications
CAS Number
2387765-27-5
Product Name Alternative
JAK2/FLT3-IN-1
UNSPSC
12352005
Target
Apoptosis; FLT3; JAK
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/flonoltinib.html
Concentration
10mM
Purity
99.48
Solubility
DMSO : 35 mg/mL (ultrasonic)
Smiles
OCCN(C1CCN(C2=CC=C(NC3=NC=C(C)C(C4=CN(C(C)C)N=C4)=N3)C=C2F)CC1)C
Molecular Formula
C25H34FN7O
Molecular Weight
467.58
References & Citations
[1]Yang T, et al. Discovery of Potent and Orally Effective Dual JAK2/FLT3 Inhibitors for the Treatment of AcuteMyelogenous Leukemia and Myeloproliferative Neoplasms. J Med Chem. 2019 Oct 31.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
JAK1; JAK2; JAK3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9002638 Inquire
Rabbit anti-Drosophila melanogaster (Fruit fly) dtr Polyclonal Antibody
Sign In for Pricing
View Details 
23180121 3x 1.0µg DNA
HELLS CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details